Dr. Mani Menon

where the Egyptian surgeons were doing an open cystectomy 15 days in a row, and then we compared data. We did that, and that's been successful. I mean, Peter Wickland, who is here, has done over 600 radical cystectomies in New York, at Sinai, in addition to the thousands he's done in Europe. But there were two things that I tried which have worked technically but have not caught on.

where the Egyptian surgeons were doing an open cystectomy 15 days in a row, and then we compared data. We did that, and that's been successful. I mean, Peter Wickland, who is here, has done over 600 radical cystectomies in New York, at Sinai, in addition to the thousands he's done in Europe. But there were two things that I tried which have worked technically but have not caught on.

One was robotic kidney transplants. It has caught on, but the main reason it hasn't caught on in the U.S. is that the transplant surgeons are not as skilled in robotics as the urologic surgeons are, and the transplant surgeons do the transplants. In India, kidney transplants are done by urologists and it's taken off. And in Europe, in many places, it has taken off.

One was robotic kidney transplants. It has caught on, but the main reason it hasn't caught on in the U.S. is that the transplant surgeons are not as skilled in robotics as the urologic surgeons are, and the transplant surgeons do the transplants. In India, kidney transplants are done by urologists and it's taken off. And in Europe, in many places, it has taken off.

One was robotic kidney transplants. It has caught on, but the main reason it hasn't caught on in the U.S. is that the transplant surgeons are not as skilled in robotics as the urologic surgeons are, and the transplant surgeons do the transplants. In India, kidney transplants are done by urologists and it's taken off. And in Europe, in many places, it has taken off.

But I had hoped that would be my swan song contributions to urology. We also... I came to the conclusion that most, if not all, people with intermediate-risk prostate cancer should not have a radical prostatectomy because the side effects of ED are about 50% across the country. If you can identify an area where there is no cancer, you can preserve it.

But I had hoped that would be my swan song contributions to urology. We also... I came to the conclusion that most, if not all, people with intermediate-risk prostate cancer should not have a radical prostatectomy because the side effects of ED are about 50% across the country. If you can identify an area where there is no cancer, you can preserve it.

But I had hoped that would be my swan song contributions to urology. We also... I came to the conclusion that most, if not all, people with intermediate-risk prostate cancer should not have a radical prostatectomy because the side effects of ED are about 50% across the country. If you can identify an area where there is no cancer, you can preserve it.

In particular, the nerves that maintain penile erection, the nerves that make nitric oxide, half the nerves are where Walsh's neurovascular bundle is. or Menon's veil, or Tuareg's hood are, but half of them are between the prostate and the seminal vesicle and around the seminal vesicle. And if you do nitric oxide staining, that's where the nerves are.

In particular, the nerves that maintain penile erection, the nerves that make nitric oxide, half the nerves are where Walsh's neurovascular bundle is. or Menon's veil, or Tuareg's hood are, but half of them are between the prostate and the seminal vesicle and around the seminal vesicle. And if you do nitric oxide staining, that's where the nerves are.

In particular, the nerves that maintain penile erection, the nerves that make nitric oxide, half the nerves are where Walsh's neurovascular bundle is. or Menon's veil, or Tuareg's hood are, but half of them are between the prostate and the seminal vesicle and around the seminal vesicle. And if you do nitric oxide staining, that's where the nerves are.

And very simply, the more nerves you preserve, the better the outcome is. And if you can figure out a way to preserve those nerves that are around the seminal vesicles, and these are microscopic nerves, you really need to stain them to see them. There's no landmark to them other than you know they're there. The potency rates are about 90%.

And very simply, the more nerves you preserve, the better the outcome is. And if you can figure out a way to preserve those nerves that are around the seminal vesicles, and these are microscopic nerves, you really need to stain them to see them. There's no landmark to them other than you know they're there. The potency rates are about 90%.

And very simply, the more nerves you preserve, the better the outcome is. And if you can figure out a way to preserve those nerves that are around the seminal vesicles, and these are microscopic nerves, you really need to stain them to see them. There's no landmark to them other than you know they're there. The potency rates are about 90%.

So this is something, a modification of radical prostatectomy that my patients called Menon's precision prostatectomy. And I've not been able to get traction on that. We've written about it. We've published it. I have eight-year data on it. And the data is robust. But for some reason, I came across it as I was in the latter part of my career.

So this is something, a modification of radical prostatectomy that my patients called Menon's precision prostatectomy. And I've not been able to get traction on that. We've written about it. We've published it. I have eight-year data on it. And the data is robust. But for some reason, I came across it as I was in the latter part of my career.

So this is something, a modification of radical prostatectomy that my patients called Menon's precision prostatectomy. And I've not been able to get traction on that. We've written about it. We've published it. I have eight-year data on it. And the data is robust. But for some reason, I came across it as I was in the latter part of my career.

Had I thought about this five years before I did, this would be the standard of care, much like nipple-sparing mastectomy for breast cancer has replaced radical mastectomy.

Had I thought about this five years before I did, this would be the standard of care, much like nipple-sparing mastectomy for breast cancer has replaced radical mastectomy.

Had I thought about this five years before I did, this would be the standard of care, much like nipple-sparing mastectomy for breast cancer has replaced radical mastectomy.